PTC THERAPEUTICS, INC.
PTCT
44 insider filings · Latest: Oct 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Apr 21 8:12 PM | Klein Matthew B. | Proposed Sale | 2,850 | $70.94 | $202.2K | — | View → |
| Apr 6, 2026 | Apr 8 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Sale | 2,265 | $69.45 | $157.3K | 105,212(D) | View → |
| Apr 2, 2026 | Apr 6 9:20 PM | Lee Scott GoldenEVP & CHIEF MEDICAL OFFICER | Sale | 829 | $67.99 | $56.4K | 79,115(D) | View → |
| Apr 6, 2026 | Apr 6 8:13 PM | Boulding Mark Elliott | Proposed Sale | 2,265 | $69.44 | $157.3K | — | View → |
| Apr 1, 2026 | Apr 3 9:20 PM | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | Sale | 52,003 | $69.04 | $3.6M | 60,137(D) | View → |
| Apr 2, 2026 | Apr 2 7:32 PM | Golden Lee Scott | Proposed Sale | 829 | $67.99 | $56.4K | — | View → |
| Apr 1, 2026 | Apr 1 8:46 PM | Almstead Neil Gregory | Proposed Sale | 52,003 | $69.04 | $3.6M | — | View → |
| Mar 12, 2026 | Mar 13 9:20 PM | Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICER | Sale | 2,662 | $64.08 | $170.6K | 396,920(D) | View → |
| Mar 10, 2026 | Mar 12 9:20 PM | Stephanie OkeyDirector | Sale | 15,167 | $70.00 | $1.1M | 8,000(D) | View → |
| Mar 12, 2026 | Mar 12 7:23 PM | Klein Matthew B. | Proposed Sale | 2,662 | $64.08 | $170.6K | — | View → |
| Mar 10, 2026 | Mar 10 6:12 PM | Okey Stephanie | Proposed Sale | 15,167 | $70.00 | $1.1M | — | View → |
| Mar 5, 2026 | Mar 9 9:20 PM | Stephanie OkeyDirector | Sale | 6,333 | $63.38 | $401.4K | 8,000(D) | View → |
| Mar 5, 2026 | Mar 9 9:20 PM | Lee Scott GoldenEVP & CHIEF MEDICAL OFFICER | Sale | 10,000 | $63.38 | $633.8K | 79,944(D) | View → |
| Mar 5, 2026 | Mar 9 9:20 PM | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | Sale | 3,989 | $63.38 | $252.8K | 2,737(I) | View → |
| Mar 5, 2026 | Mar 5 6:41 PM | Okey Stephanie | Proposed Sale | 6,333 | $63.38 | $401.4K | — | View → |
| Mar 5, 2026 | Mar 5 4:40 PM | Almstead Zheng Yang | Proposed Sale | 3,989 | $63.38 | $252.8K | — | View → |
| Mar 5, 2026 | Mar 5 4:16 PM | Golden Lee Scott | Proposed Sale | 10,000 | $63.38 | $633.8K | — | View → |
| Feb 19, 2026 | Feb 23 10:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Sale | 3,019 | $69.48 | $209.8K | 105,212(D) | View → |
| Feb 18, 2026 | Feb 20 10:20 PM | Christine Marie UtterSVP, CHIEF ACCOUNTING OFFICER | Sale | 2,494 | $69.36 | $173.0K | 70,199(D) | View → |
| Feb 18, 2026 | Feb 20 10:20 PM | Pierre GravierCHIEF FINANCIAL OFFICER | Sale | 2,992 | $69.36 | $207.5K | 87,318(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Apr 8 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Option Exercise | 2,265 | $39.42 | 6,798(D) | View → |
| Mar 24, 2026 | Mar 26 11:41 PM | Jessica Caroline ChutterDirector | Grant/Award | 6,371 | $64.54 | 2,896(D) | View → |
| Mar 10, 2026 | Mar 12 9:20 PM | Stephanie OkeyDirector | Option Exercise | 15,167 | $33.63 | 0(D) | View → |
| Feb 17, 2026 | Feb 19 10:25 PM | Mark Elliott BouldingEXEC. VP AND CLO | Option Exercise | 2,813 | $25.69 | 22,501(D) | View → |
← Previous
Page 2 of 2